Zacks Sell List Highlights: Alon USA Energy, Inc., Curtiss-Wright Corp., Ralcorp Holdings, Inc. and Emergent BioSolutions Inc.
2009-11-24 23:08:03 -
Zacks.com releases details on a group of stocks that are currently members of the exclusive Zacks #5 Rank List – Stocks to Sell Now. These stocks are currently rated as a Zacks Rank #5 (Strong Sell): Alon USA Energy, Inc. (NYSE: ALJ : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww .. ) and Curtiss-Wright Corp. (NYSE: CW : cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww .. ).
Further, Zacks announced #4 Rankings
(Sell) on two other widely held stocks: Ralcorp Holdings, Inc. (NYSE: RAH :
cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww .. ) and Emergent BioSolutions Inc. (NYSE: EBS :
cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww .. ).
To see the full Zacks #5 Rank List - Stocks to Sell Now visit:
at.zacks.com/?id=92 :
cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fat. ..
Since inception in 1988, the S&P 500 has outperformed the Zacks #5 Rank List of Stocks to Sell Now by 80% annually (+2% vs. +10%). While the rest of Wall Street continued to tout stocks during the market declines of the last few years, Zacks told investors which stocks to sell or avoid.
Here is a synopsis of why ALJ and CW have a Zacks Rank of #5 (Strong Sell) and should most likely be sold or avoided for the next one to three months. Note that a #5 Strong Sell rating is applied to 5% of all the stocks in the Zacks Rank universe.
Alon USA Energy, Inc. (NYSE: ALJ :
cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww .. ) swung to a third-quarter loss of 56 cents per share on Nov 4, compared to the Zacks Consensus Estimate of a loss of 18 cents. In the year-ago quarter the company earned a profit of 52 cents per share. Sales fell 34% to $1.25 billion. The full-year average forecast now stands at a loss of $1.04 per share, wider than last month’s projection of a loss of 41 cents. Four out of 6 analysts cut back on estimates during that time.
Curtiss-Wright Corp. (NYSE: CW :
cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww .. ) lowered its full-year earnings guidance to a range of $2.05 to $2.15 per share from a prior view of $2.35 to $2.45. Analysts now expect the company to post earnings of $2.07 per share. Last month, Curtiss-Wright reported third-quarter earnings of 51 cents per share, which came in 19% below analysts’ expectations. This apart, earnings fell 15% on a year-over-year basis.
Here is a synopsis of why RAH and EBS have a Zacks Rank of 4 (Sell) and should also most likely be sold or avoided for the next one to three months. Note that a #4 Sell rating is applied to 15% of all the stocks ranked by Zacks;
Ralcorp Holdings, Inc. (NYSE: RAH :
cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww .. ) reported fourth-quarter earnings of $1.14 per share on Nov 10 while the Zacks Consensus Estimate was pegged at $1.24. The company’s earnings fell 39%, in contrast to last year’s figures. The average forecast for the full year declined 17 cents to $4.76 per share in the last 30 days as 6 out of 10 analysts lowered estimates.
Emergent BioSolutions Inc.’s (NYSE: EBS :
cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww .. ) third-quarter profit of 3 cents per share, reported earlier this month, missed the Zacks Consensus Estimate by 50%. EPS results marked a 91% decrease year over year. Revenues dipped to $43.3 million, compared with $56.6 million in the prior-year quarter. The 2009 average forecast fell 2 cents to 98 cents per share in the last month as 1 out of 2 covering analysts pulled back on expectations.
Truly taking advantage of the Zacks Rank requires the understanding of how it works. The free special report; “Zacks Rank Guide: Harnessing the Power of Earnings Estimate Revisions” is available to provide this insightful background. Download a free copy now to prosper in the years to come at
at.zacks.com/?id=93 :
cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fat. ..
About the Zacks Rank
Since 1988, the Zacks Rank has proven that "Earnings estimate revisions are the most powerful force impacting stock prices." Since inception in 1988, #1 Rank Stocks have generated an average annual return of +27%.
During the 2000-2002 bear market, Zacks #1 Rank stocks gained +43.8%, while the S&P 500 tumbled -37.6%. Also note that the Zacks Rank system has just as many Strong Sell recommendations (Rank #5) as Strong Buy recommendations (Rank #1). Since 1988, Zacks Rank #5 stocks have significantly underperformed the S&P 500 (-0.9% versus +9%). Thus, the Zacks Rank system allows investors to truly manage portfolio trading effectively.
Visit
www.zacks.com/performance :
cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww .. for information about the performance numbers displayed in this press release.
Zacks “Profit from the Pros” e-mail newsletter offers continuous coverage of Zacks Rank Buy stocks and highlights those stocks poised to outperform the market. Subscribe to this free newsletter today by visiting
at.zacks.com/?id=94 :
cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fat. ..
About Zacks
Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew he could find patterns in stock market data that would lead to superior investment results. Amongst his many accomplishments was the formation of his proprietary stock picking system; the Zacks Rank, which continues to outperform the market by nearly a 3 to 1 margin. The best way to unlock the profitable stock recommendations and market insights of Zacks Investment Research is through our free daily email newsletter; Profit from the Pros. In short, it's your steady flow of Profitable ideas GUARANTEED to be worth your time! Register for your free subscription to Profit from the Pros at
at.zacks.com/?id=95 :
cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fat. ..
Follow us on Twitter:
twitter.com/zacksresearch :
cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Ftwi ..
Join us on Facebook:
www.facebook.com/home.php#/pages/Zacks-Investment-Research/57553 .. :
cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww ..
Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.
Disclaimer: Past performance does not guarantee future results.
Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
Zacks.comMichael Vodicka312-265-9226Email:
pr@zacks.com : mailto:pr@zacks.com Visit:
www.Zacks.com :
cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww ..